microbiome

SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study
SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study
CP Wire
SkinBio Therapeutics
microbiome
Flag link:
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
CP Wire
Vedanta Biosciences
microbiome
VE800
Flag link:
Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate
Vedanta Biosciences
microbiome
Flag link:
SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study
SkinBio Therapeutics
microbiome
Flag link:
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development
CP Wire
Microbiome Insights
Rebiotix
IBD
diagnostics
microbiome
Flag link:
Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development
Microbiome Insights
Rebiotix
IBD
diagnostics
microbiome
Flag link:
MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
CP Wire
MaaT Pharma
acute myeloid leukemia
microbiome
Flag link:
MaaT Pharma Releases Results Of Microbiome Restoration Therapy in Acute Myeloid Leukemia Patients
MaaT Pharma
acute myeloid leukemia
microbiome
Flag link:
Microbiome Report for Week Ending 10/27/18
Microbiome Report for Week Ending 10/27/18
CP Wire
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Flag link:
Microbiome Report for Week Ending 10/27/18
Enterome
Takeda Pharmaceuticals
Microbiotica
microbiome
Flag link:
Microbiome Report for Week Ending 10/20/18
Microbiome Report for Week Ending 10/20/18
CP Wire
LNC Therapeutics
Synthetic Biologics
microbiome
Flag link:
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
Seres Therapeutics Appoints Industry Veteran as Chief Medical Officer
CP Wire
Seres Therapeutics
microbiome
Flag link:
Symberix Announces Non-Dilutive Funding Support for Lead Programs
Symberix Announces Non-Dilutive Funding Support for Lead Programs
CP WIre
Symberix
microbiome
Flag link:
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
CP Wire
LNC Therapeutics
microbiome
obesity
Flag link:
Symberix Announces Non-Dilutive Funding Support for Lead Programs
Symberix
microbiome
Flag link:
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
LNC Therapeutics
microbiome
Flag link:
Lab to study impact of genetics, microbiome on substance use
Lab to study impact of genetics, microbiome on substance use
Washington Times
Jackson Laboratory
microbiome
substance abuse
Flag link:
Microbiome Report for Week Ending 9/29/18
Microbiome Report for Week Ending 9/29/18
CP Wire
microbiome
Second Genome
4D Pharma
Thetanix
Flag link:
Microbiome Report for Week Ending 9/29/18
microbiome
Second Genome
4D Pharma
Thetanix
Flag link:
Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018
Rebiotix to Present Data From First-In-Class Microbiota Restoration Therapy at IDWeek 2018
CP Wire
Rebiotix
RBX2660
C. difficile
microbiome
Flag link:

Pages